Dr. Reddy's Laboratories
149 hedge funds and large institutions have $931M invested in Dr. Reddy's Laboratories in 2013 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 43 increasing their positions, 58 reducing their positions, and 15 closing their positions.
53% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 15
11% more capital invested
Capital invested by funds: $837M → $931M (+$94M)
6% more funds holding
Funds holding: 141 → 149 (+8)
1.22% more ownership
Funds ownership: 65.19% → 66.41% (+1.2%)
25% less call options, than puts
Call options by funds: $513K | Put options by funds: $685K
26% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 58
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Schroder Investment Management Group
London,
United Kingdom
|
+$15.4M |
| 2 |
CCM
Causeway Capital Management
Los Angeles,
California
|
+$10.2M |
| 3 |
JP Morgan Chase
New York
|
+$9.58M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
+$9.23M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
+$6.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$9.74M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$9.54M |
| 3 |
CBOA
Commonwealth Bank of Australia
Sydney, NSW,
Australia
|
-$4.99M |
| 4 |
Zurich Cantonal Bank
Zurich,
Switzerland
|
-$4.22M |
| 5 |
IG
ING Group
Amsterdam,
Netherlands
|
-$3.88M |
RDY Hedge Fund Activity: Q4 2013 in Review
149 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q4 2013, worth a combined $931M — up 11% from $837M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new RDY positions and 15 closed out — a net gain of 8 holders — while 43 added to existing stakes and 58 trimmed.
The largest buyer was Schroder Investment Management Group, adding an estimated $15.4M. The largest seller was Jane Street, cutting an estimated $9.74M.
- 149 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q4 2013, up from 141 in Q3 2013.
- Funds reported $931M of Dr. Reddy's Laboratories stock for Q4 2013, up 11% quarter-over-quarter.
- 23 funds opened new Dr. Reddy's Laboratories positions in Q4 2013 and 15 closed out, a net change of +8 holders.
- The largest Dr. Reddy's Laboratories buyer in Q4 2013 was Schroder Investment Management Group, an estimated $15.4M added.
- The largest Dr. Reddy's Laboratories seller in Q4 2013 was Jane Street, an estimated $9.74M sold.
Based on aggregated 13F filings for Q4 2013.